A plant‐derived edible vaccine against hepatitis B virus
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The infectious hepatitis B virus represents 42 nm spherical double‐shelled particles. However, analysis of blood from hepatitis B virus carriers revealed the presence of smaller 22 nm particles consisting of a viral envelope surface protein. These particles are highly immunogenic and have been used in the design of hepatitis B virus vaccine produced in yeast. Upon expression in yeast, these proteins form virus‐like particles that are used for parenteral immunization. Therefore, the DNA fragment encoding hepatitis B virus surface antigen was introduced into Agrobacterium tumerifacience LBA4404 and used to obtain transgenic lupin ( Lupinus luteus L .) and lettuce ( Lactuca sativa L .) cv. Burpee Bibb expressing envelope surface protein. Mice that were fed the transgenic lupin tissue developed significant levels of hepatitis B virus‐specific antibodies. Human volunteers, fed with transgenic lettuce plants expressing hepatitis B virus surface antigen, developed specific serum‐IgG response to plant produced protein.—Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., Legocki, A. B. A plant‐derived edible vaccine against hepatitis B virus. FASEB J . 13, 1796–1799 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Production of antibodies in transgenic plants
Hiatt, A., Caffferkey, R., & Bowdish, K. (1989) · Nature · doi:10.1038/342076a0 · Cited by 1,059
Oral Immunization with a Recombinant Bacterial Antigen Produced in Transgenic Plants
Haq, T. A., Mason, H. S., Clements, J. D., & Arntzen, C. J. (1995) · Science · doi:10.1126/science.7732379 · Cited by 622
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
Tacket, C. O., Mason, H. S., Losonsky, G., Clements, J. D., Levine, M. M., & Arntzen, C. J. (1998) · Nature Medicine · doi:10.1038/nm0598-607 · Cited by 581
Efficacy of a food plant-based oral cholera toxin B subunit vaccine
Arakawa, T., Chong, D. K. X., & Langridge, W. H. R. (1998) · Nature Biotechnology · doi:10.1038/nbt0398-292 · Cited by 347
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
The production of recombinant pharmaceutical proteins in plants
Ma, J. K.-C., Drake, P. M. W., & Christou, P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1177 · Cited by 960
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
Daniell, H., Streatfield, S. J., & Wycoff, K. (2001) · Trends in Plant Science · doi:10.1016/s1360-1385(01)01922-7 · Cited by 750
Molecular farming in plants: host systems and expression technology
Twyman, R. M., Stoger, E., Schillberg, S., Christou, P., & Fischer, R. (2003) · Trends in Biotechnology · doi:10.1016/j.tibtech.2003.10.002 · Cited by 693
Plant-based production of biopharmaceuticals
Fischer, R., Stoger, E., Schillberg, S., Christou, P., & Twyman, R. M. (2004) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2004.01.007 · Cited by 634
Kushnir, N., Streatfield, S. J., & Yusibov, V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.083 · Cited by 587
Self-citationBiotechnology Applications of Plant Callus Cultures
Efferth, T. (2019) · Engineering · doi:10.1016/j.eng.2018.11.006 · Cited by 442
Plant-made vaccine antigens and biopharmaceuticals
Daniell, H., Singh, N. D., Mason, H., & Streatfield, S. J. (2009) · Trends in Plant Science · doi:10.1016/j.tplants.2009.09.009 · Cited by 405
Daniell, H., Lee, S.-B., Panchal, T., & Wiebe, P. O. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4921 · Cited by 398
Molecular farming of pharmaceutical proteins
Fischer, R., & Emans, N. (2000) · Transgenic Research · doi:10.1023/a:1008975123362 · Cited by 394
D’Aoust, M., Couture, M. M. ‐., Charland, N., Trépanier, S., Landry, N., Ors, F., & Vézina, L. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00496.x · Cited by 371
Plant‐made vaccines for humans and animals
Rybicki, E. P. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2010.00507.x · Cited by 334
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine
YUSIBOV, V (2002) · Vaccine · doi:10.1016/s0264-410x(02)00260-8 · Cited by 311
Self-citationEffect of vaccine administration modality on immunogenicity and efficacy
Zhang, L., Wang, W., & Wang, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1081067 · Cited by 255
Genetically modified plants and human health
Key, S., Ma, J. K.-C., & Drake, P. M. (2008) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.070372 · Cited by 197
Metadata
- Authors
- Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., & Legocki, A. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 13
- Issue
- 13
- Pages
- 1796-1799
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1705041761
- Cited by
- 386
- References
- 5
- FWCI
- 12.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.